Novo Nordisk A/S (CPH: NOVO.B)

Novo Nordisk Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,207,116	3,112,331	2,118,803	1,674,992	986,612	909,347
Market Cap Growth	21.09%	46.89%	26.50%	69.77%	8.50%	27.49%
Enterprise Value	3,189,207	3,091,273	2,107,299	1,653,350	965,236	894,933
Last Close Price	721.80	690.44	458.03	353.60	201.34	178.54
PE Ratio	34.05	37.08	37.48	34.10	22.36	21.80
Forward PE	27.28	32.62	40.03	34.03	21.33	21.14
PS Ratio	11.89	13.40	11.97	11.90	7.77	7.45
PB Ratio	26.66	29.21	25.38	23.68	15.58	15.79
P/TBV Ratio	52.81	67.43	65.10	60.74	23.12	17.57
P/FCF Ratio	41.25	37.45	31.75	34.42	21.39	24.03
P/OCF Ratio	29.50	28.58	26.86	30.45	18.99	19.44
PEG Ratio	1.34	1.74	2.45	3.07	2.31	2.58
EV/Sales Ratio	11.79	13.31	11.91	11.74	7.60	7.33
EV/EBITDA Ratio	24.77	28.15	26.06	25.93	16.48	15.89
EV/EBIT Ratio	26.61	29.73	27.89	27.92	17.83	17.05
EV/FCF Ratio	41.02	37.20	31.57	33.97	20.93	23.64
Debt / Equity Ratio	0.47	0.25	0.31	0.38	0.16	0.08
Debt / EBITDA Ratio	0.44	0.24	0.31	0.41	0.17	0.08
Debt / FCF Ratio	0.73	0.32	0.39	0.55	0.22	0.12
Asset Turnover	0.78	0.84	0.81	0.83	0.94	1.03
Inventory Turnover	1.23	1.27	1.29	1.24	1.16	1.18
Quick Ratio	0.74	0.62	0.67	0.65	0.64	0.76
Current Ratio	0.94	0.82	0.89	0.86	0.94	1.06
Return on Equity (ROE)	88.73%	88.07%	72.00%	71.24%	69.70%	71.19%
Return on Assets (ROA)	21.47%	23.39%	21.68%	21.81%	25.01%	27.75%
Return on Capital (ROIC)	50.41%	53.53%	45.71%	43.27%	49.84%	57.33%
Earnings Yield	2.94%	2.69%	2.62%	2.85%	4.27%	4.28%
FCF Yield	2.42%	2.67%	3.15%	2.91%	4.68%	4.16%
Dividend Yield	1.34%	1.36%	1.35%	1.47%	2.26%	2.34%
Payout Ratio	46.60%	37.96%	45.57%	45.06%	47.75%	49.83%
Buyback Yield / Dilution	0.86%	1.10%	1.34%	1.58%	1.63%	1.89%
Total Shareholder Return	2.20%	2.46%	2.69%	3.05%	3.89%	4.22%

Source: S&P Capital IQ. Standard template. Financial Sources.